Cannon Global Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,800
Closed -$408K 86
2026
Q1
$408K Buy
21,800
+5,300
+32% +$101K 0.8% 45
2025
Q4
$381K Sell
16,500
-15,412
-48% -$397K 0.96% 44
2025
Q3
$857K Buy
+31,912
New +$761K 1.29% 18

Other funds holding STAA

Cannon Global Investment Management's STAA Position: Q2 2026 in Review

Cannon Global Investment Management sold out of STAAR Surgical (STAA) in Q2 2026, closing a stake of 21,800 shares — an estimated $408K sold.

Cannon Global Investment Management first reported a position in STAA in Q3 2025 and held it in 3 quarters. The position peaked at $857K in Q3 2025. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Cannon Global Investment Management reported no remaining STAAR Surgical position as of Q2 2026 after selling out during the quarter.
  • Cannon Global Investment Management sold 21,800 STAAR Surgical shares in Q2 2026, an estimated $408K.
  • Cannon Global Investment Management first reported a position in STAAR Surgical in Q3 2025 and held it in 3 quarters.
  • Cannon Global Investment Management's STAAR Surgical position peaked at $857K in Q3 2025.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Cannon Global Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.